Non-Therapeutic Protocol
SJCIT: Constraint Induced Movement Therapy in a Pediatric Oncology Population
Type of Protocol/Clinical Study
Associated Brain Tumor Studies : CNS malignancies; hemiplegia
Description
Hemiplegia is a neurological impairment which can occur in children as a result of a brain tumor. With hemiplegia, one’s arm is often difficult to use and functional abilities such as performing daily activities are limited. Constraint Induced Therapy (CI) is a rehabilitation technique found to improve children’s abilities to move and use their arms following neurological injuries. The aim of this study is to evaluate the feasibility of a constraint induced movement therapy program in a small group of children with a brain tumor and hemiplegia. The program includes restraining the strong arm and forcing use of the weaker arm during three weeks of occupational therapy treatment. Participants may experience improved ability to use their weak arm.
Objectives
- To evaluate the feasibility of conducting a 3 week constraint induced therapy program in patients with upper extremity hemiplegia as a result of tumor.
- To describe the change in amount of extremity use and quality of use at pre intervention, post intervention and at follow up.
Eligibility
Only current St. Jude patients are eligible for non-therapeutic studies.
Eligibility Criteria
- Participant has a diagnosis of hemiplegia of an upper extremity.
- Participant has a diagnosis of brain tumor.
- Participant is not receiving chemotherapy or radiation therapy.
- Participant is between 2 and 7 years of age.
- Participant does not have uncontrolled seizures.
- Participant does not have pain that considerably affects with their ability to participate.
Principal Investigator
Jessica Sweeney
The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.